A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects

Summary

This is a randomized, open, parallel, single center phase I clinical trial to evaluate the impact of food on the pharmacokinetics of TQB3454 tablets in healthy adult subjects. The aim is to evaluate the impact of food on the pharmacokinetics as well as the safety after single dose of TQB3454 tablets taken orally by Chinese healthy adult subjects, with pharmacokinetic indicators as the primary endpoint.

Timeline

Start

2023-11

Primary completion

2023-12

Completion

2023-12

Drugs

Indications